check_circleStudy Completed

Magnetic Resonance Imaging

Gd-DTPA (SH L 451 AA) in MR tomography for the demonstration and demarcation of lesions in the region of the cranium and trunk

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

6 - 78 Years
  • -

  • -

Trial summary

Enrollment Goal
542
Trial Dates
June 1986 - July 1987
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteer
N/A

Trial design

Tolerance and diagnostic quality of Gd-DTPA (SH L 451 AA) in MR tomography for the demonstration and demarcation of lesions in the region of the cranium and trunk
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A